BioSpace News Archive

The global blood glucose test strips market displays fierce competition among the prominant players.

TeraRecon, the market leader in Advanced Visualization and Artificial Intelligence solutions for medical imaging, welcomes two new members to its executive team.

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, announced that Erin Quirk, M.D., Chief Medical Officer, will present a corporate overview and update on the Company’s lead clinical programs at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020.

Beacon Targeted Therapies, a Hanson Wade Ltd company, is a leader in bespoke and tailored clinical trial and drug development database products in targeted therapies providing accurate, in-depth, and real-time information on the rapidly evolving drug development landscapes.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are: Merck to acquire Themis Bioscience, a company focused on vaccines and immune-modulati

Sensor Electronic Technology, Inc. (“SETi”), the World’s first compound semiconductor for UV LED solutions (Violeds) and Seoul Viosys (KOSDAQ: 092190)’ subsidiary, announced that it launches portable air purifiers with Violeds technology, brand “VAC”, to reduce infection from various harmful bacteria including new coronavirus (SARS-CoV-2) in the air. The online sales of the products will be started in both South Korea and

CytomX Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, announced it will host a conference call and audio webcast on Friday, May 29, 2020 from 5:00 p.m. to 6:00 p.m. ET / 2:00 p.m. to 3:00 p.m. PT.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 2-4, 2020.

Brilacidin showed a dose-dependent inhibitory response in a human kidney cell line expressing hACE2